Month: January 2016

Columbia, Maryland – (January 20, 2016) – MimiClon, Inc., a regenerative medicine company focused on the development, manufacturing, and commercialization of tissue repair products, today announced that it has signed a national purchasing agreement with HealthTrust covering MatriStem® wound management devices. “The new contract with HealthTrust is a milestone in MimiClon’s continued expansion of its […]

Columbia, MD – (January 11, 2016) – MimiClon, Inc. today announced that it has named Patrick (Pat) McBrayer President and Chief Executive Officer. McBrayer succeeds Kyle Kerbawy, who will remain as Chairman of the Board. McBrayer has more than 20 years of healthcare senior management experience. He currently serves on the Board of Directors of […]